Assess the pathogenesis and progression of myelofibrosis, including underlying pathophysiologic mechanisms and the most frequently related primary mutations
Examine the patient burden of myelofibrosis, reviewing its prevalence, clinical manifestations, and evidence-supported risk stratification and diagnostic strategies
Appraise the current treatment landscape for myelofibrosis, identifying healthcare disparities and inequities while focusing on areas of greatest unmet need for patients
Explore therapeutic targets for myelofibrosis treatments
Using a case-based approach, design individualized treatment plans for patients with myelofibrosis, highlighting clinical scenarios commonly encountered by the advanced practitioner, including recognition, mitigation, and management of adverse events